INVO Bioscience Inc (INVO)
0.985
-0.02
(-1.50%)
USD |
NASDAQ |
May 17, 16:00
0.9836
0.00 (0.00%)
After-Hours: 20:00
INVO Bioscience Cash from Investing (Quarterly): 0.0333M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0333M |
| September 30, 2023 | -2.258M |
| June 30, 2023 | -0.2615M |
| March 31, 2023 | -0.0084M |
| December 31, 2022 | 0.0086M |
| September 30, 2022 | -0.003M |
| June 30, 2022 | -0.0049M |
| March 31, 2022 | -0.0819M |
| December 31, 2021 | -0.9178M |
| September 30, 2021 | -0.3203M |
| June 30, 2021 | -0.6064M |
| March 31, 2021 | -0.309M |
| December 31, 2020 | -0.0966M |
| September 30, 2020 | -0.061M |
| June 30, 2020 | -0.0046M |
| March 31, 2020 | -0.0251M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | -0.0499M |
| June 30, 2019 | -0.0164M |
| March 31, 2019 | -0.0484M |
| December 31, 2018 | -0.0194M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | -0.0077M |
| September 30, 2016 | -0.008M |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2011 | |
| September 30, 2011 | 0.00 |
| June 30, 2011 | |
| March 31, 2011 | 0.00 |
| December 31, 2010 | |
| September 30, 2010 | 0.00 |
| June 30, 2010 | |
| March 31, 2010 | 0.00 |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | 0.00 |
| March 31, 2009 | |
| December 31, 2008 | -0.0739M |
| September 30, 2008 | 0.0073M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.258M
Minimum
Sep 2023
0.0333M
Maximum
Dec 2023
-0.2623M
Average
-0.0499M
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -425.00M |
| Perspective Therapeutics Inc | -47.30M |
| Xtant Medical Holdings Inc | -0.674M |
| Asensus Surgical Inc | 3.00M |
| Catheter Precision Inc | -0.022M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.7149M |
| Cash from Financing (Quarterly) | -0.1415M |
| Free Cash Flow | -5.200M |
| Free Cash Flow Per Share (Quarterly) | -0.3169 |
| Free Cash Flow to Equity (Quarterly) | -0.7562M |
| Free Cash Flow to Firm (Quarterly) | -0.6057M |
| Free Cash Flow Yield | -375.4% |